Shai Gozani - Feb 2, 2025 Form 4 Insider Report for NeuroMetrix, Inc. (NURO)

Role
Director
Signature
/s/ Thomas T. Higgins, Attorney-in-fact
Stock symbol
NURO
Transactions as of
Feb 2, 2025
Transactions value $
-$340
Form type
4
Date filed
2/5/2025, 08:04 PM
Previous filing
Feb 5, 2025
Next filing
Apr 3, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NURO Common Stock Options Exercise $2.74K +636 +4.43% $4.31 15K Feb 2, 2025 Direct F1
transaction NURO Common Stock Tax liability -$340 -79 -0.53% $4.31 14.9K Feb 2, 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NURO Restricted Stock Unit Options Exercise -$2.74K -636 -50.08% $4.31 634 Feb 2, 2025 Common Stock 636 $4.31 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares earned upon the vesting of restricted stock units referenced in footnote 3.
F2 Represents shares withheld in payment of withholding taxes upon vesting of the restricted stock units reference in footnote 3.
F3 On May 24, 2022, the reporting person was granted 61,029 restricted stock units prior to the reverse split of the Issuer's common stock at ratio of 1-for-8, effective as of November 21, 2023, which vest in equal quarterly installments over three years beginning on August 2, 2022.